Study on the Priorities of Patients Admitted to Intensive Care (PRIOREA)

The goal of this observational study is to learn about the priorities of patients admitted to intensive care units (ICUs) who have a life-threatening condition, as well as the priorities assumed by their designated relatives and healthcare professionals (nurses, nursing assistants, ICU physicians, and general practitioners).

Study Overview

• Status: Not yet recruiting
• Conditions: Intensive Care Unit Syndrome

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Thomas GARGADENNEC, MD; Phone Number: +33 02 30 33 78 94; Email: thomas.gargadennec@chu-brest.fr

Study Locations

• France
  • Brest, France, 29200
    • CHU de Brest
    • Contact: Thomas GARGADENNEC, MD; Phone Number: +33 02 30 33 78 94; Email: thomas.gargadennec@chu-brest.fr
    • Principal Investigator: Thomas GARGADENNEC, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patient admitted to intensive care Contact person for patients admitted to intensive care Caregiver for patients admitted to intensive care Family doctor for patients admitted to intensive care

Description

Inclusion criteria for Patient:

• Adult Patient
• Estimated length of stay in intensive care exceeding 72 hours
• No objection from the patient or the designated representative, if the patient is unable to consent to participate in the study

Inclusion criteria for Designated representative:

• Adult Person
• No objection to participate in the study

Inclusion criteria for Caregiver:

• No objection to participate in the study

Exclusion criteria :

• Patients under legal protection (guardianship, conservatorship)
• Pregnant or breastfeeding women
• Disagreement among the patient's relatives regarding the designated representative.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Agreement rate	Assessment of the consistency between the priorities of patients and/or those assumed by the referring person and the priorities assumed by caregivers (resuscitation team and attending physician, if possible).	48 hours

Collaborators and Investigators

• Sponsor: University Hospital, Brest

Study record dates

Study Major Dates

• Study Start (Estimated): February 15, 2026
• Primary Completion (Estimated): August 15, 2027
• Study Completion (Estimated): November 14, 2027

Study Registration Dates

• First Submitted: February 11, 2026
• First Submitted That Met QC Criteria: February 11, 2026
• First Posted (Actual): February 18, 2026

Study Record Updates

• Last Update Posted (Actual): March 5, 2026
• Last Update Submitted That Met QC Criteria: March 3, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 29BRC25.0322; 2025-A02336-43 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: All collected data that underlie results in a publication
• IPD Sharing Time Frame: Data will be available beginning five years and ending fifteen years following the final study report completion
• IPD Sharing Access Criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No